Triptorelin
Also known as Triptoreline, Triptorelina, Triptorelinum, [D-Trp6]-GnRH
Research Goal: Analyzing pituitary desensitization and hormonal suppression or the "restart" (recovery) effect of a single pulse dose.
Route
Subcutaneous injection
Dose range
100 mcg – 3.75 mg
Frequency
Cycle length
Dependent on goal (One-time pulse vs. monthly suppression)
Overview
Research Goal: Analyzing pituitary desensitization and hormonal suppression or the "restart" (recovery) effect of a single pulse dose.
Preparation: Reconstitute with 1.0 mL sterile water. Extremely sensitive peptide; requires careful handling to prevent degradation.
Studied benefits
- A potent GnRH agonist
- In low, pulsatile research doses, it has been used to "restart" the natural production of testosterone (HPTA axis) following suppression
- In clinical medicine, higher doses are used to manage hormone-sensitive conditions by temporarily suppressing sex hormones
Reported side effects
- Potential for "hot flashes," temporary mood swings, or injection-site soreness
- Note: Overuse or high doses can cause profound hormonal suppression (chemical castration), so precise dosing is critical
Protocol
Dosing Schedule (Subcutaneous)
Educational reference only. Not medical advice. Research compounds are not approved for human use. Full disclaimer.
| Protocol | Dose (mcg/mg) | Draw at 2.5 mg/mL | Log |
|---|---|---|---|
| "GnRH Restart" | 100 mcg (0.1 mg) | 4 units (0.04 mL) | + Log |
| Suppression Study | 3.75 mg | 150 units (1.5 mL) | + Log |
Timing
Morning administration preferred.
Cycle length
Dependent on goal (One-time pulse vs. monthly suppression).
- Note: In recovery research, it is strictly used as a single pulse to avoid permanent pituitary desensitization.
Unit calculator
Set your vial and water; the table above updates.
2.5 mg/mL
50 doses of 100 mcg per vial
Assumes a U-100 insulin syringe (100 units = 1 mL). Educational math only; verify every calculation yourself.
Context
Lifestyle considerations
Maintain a nutrient-dense, balanced diet rich in healthy fats and zinc to support the endocrine system during the potent stimulation of the GnRH receptors. Stay physically active to maintain metabolic health, but monitor for transient hormonal shifts that may affect energy levels or mood. Ensure 7–9 hours of quality sleep for optimal endocrine recovery and to manage systemic stress. Use extreme caution with dosing frequency, as research indicates that over-stimulation can lead to the down-regulation of the pituitary gland and a subsequent suppression of testosterone and estrogen production.
Evidence
Research summaries
Triptorelin for central precocious puberty (Protocol)
Findings: Slows down early puberty in kids, letting them grow taller and develop at a normal pace.
Kids with central precocious puberty (CPP) start puberty way too young—like breasts or body hair at age 5. This study reviewed triptorelin shots, which mimic then block the hormone signal for puberty. After 2-3 years, treated kids stopped early signs: no more rapid growth spurts that make them short adults, breasts shrank back, periods paused in girls. Height predictions improved by inches because bones got more time to lengthen before closing. Side effects were mild, like temporary hot flashes or mood dips, but overall safe. Doctors measure LH/FSH hormones—they dropped fast, proving it works. Big win: normal teen years without bullying over looking older. Used in clinics worldwide for thousands of kids. (Note: PubMed Cochrane review.)
Read the study ↗Long-term efficacy and safety of triptorelin rather than monthly leuprolide in central precocious puberty
Findings: Controls puberty longer with fewer shots, safer for bones and mood than other drugs.
Comparing triptorelin (every 3 months) to monthly leuprolide in 70+ kids with CPP. Triptorelin kept puberty hormones suppressed better over 3 years—LH stayed low, growth velocity normalized (kids grew steadily, not too fast). Bone age advanced slower, predicting taller adult height. Fewer injections meant less pain/stress. Safety shine: no major bone thinning (DXA scans good), moods stable, no weight gain issues. Suppresses estrogen/testosterone surges that cause early changes. Clinical benefit? Kids hit puberty right on time when stopped, looking and feeling age-appropriate. Perfect for busy families—long-acting depot form releases steadily.
Read the study ↗Triptorelin stimulation test in the evaluation of hormonal status in girls with early breast development
Findings: Helps diagnose early puberty accurately, guiding treatment to prevent health risks.
For girls 6-8 with breast buds (early sign of puberty), a single triptorelin injection tests if brain signals are firing too soon. LH jumps over 5 IU/L means true CPP—treatable. In 200+ girls, it caught 80% needing therapy, avoiding overtreatment. Benefits: prevents short stature (bones fuse early), emotional stress, or future infertility risks from hormone chaos. Accurate diagnosis means targeted care. Follow-up showed treated girls had normal development. Quick test (blood draw 60 min post-shot), outpatient-safe. Gold standard now, per pediatric endocrinologists.
Read the study ↗Triptorelin in advanced prostate cancer: Effects on hormone levels and tumor markers
Findings: Shrinks prostate tumors by crashing male hormones, easing pain and slowing cancer spread.
In men with prostate cancer, monthly triptorelin drops testosterone to "castrate levels" (like surgery), starving hormone-sensitive tumors. PSA (cancer marker) fell 90% in responders, tumors shrank on scans, bone pain eased in 70%. Lasted 1-2 years before resistance, but combo with other drugs extends it. Better than old therapies—no heart risks like estrogens. Clinical wins: longer survival, better quality life (less urinary issues, stronger bones with add-ons). Millions treated globally. Initial flare managed with anti-androgens.
Read the study ↗Identification
Chemistry
- common names
- Triptorelin, Triptoreline, Triptorelina, Triptorelinum, [D-Trp6]-GnRH, [D-Trp6]-LHRH, (6-D-Tryptophan)luteinizing hormone-releasing hormone
- source
- Synthetic; not naturally occurring; rationally designed analog of endogenous GnRH
- biosynthesis
- Nonribosomal peptide; synthesized via solid-phase peptide synthesis (Fmoc-based SPPS protocols)
- type
- Linear decapeptide with:
Keep exploring
Related peptides
Gonadorelin
- Route
- Subcutaneous
- Dose
- 250–1000 IU
- Cycle
- 8–16 weeks
HMG (Human Menopausal Gonadotropin)
Human Menopausal Gonadotropin
- Route
- Subcutaneous
- Dose
- 0.15–75 IU
- Cycle
- 12–16 weeks
Kisspeptin-10
- Route
- Subcutaneous
- Dose
- 100 mcg – 200 mcg
- Cycle
- 8–12 weeks
Melanotan 2 (MT2)
MT2
- Route
- Subcutaneous
- Dose
- 250 mcg – 1 mg
- Cycle
- 6–8 weeks